Baxter International Inc (BAX)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$18.60

Buy

$19.38

arrow-up$0.25 (+1.32%)

Prices updated at 13 Dec 2025, 00:41 EST

Prices minimum 15 mins delay

Prices in USD

Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. D. Brent Shafer

CEO

Mr. Andrew P. Hider

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

38,000

Head office

One Baxter Parkway

Deerfield

United States

60015

+1 224 948-2000

Global_CORP_Investor_Relations@baxter.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Joel T. Grade Executive Vice President and Chief Financial Officer	0.81m
Mr. D. Brent Shafer Chairman of the Board	0.17m
Ms. Anita A. Zielinski Senior Vice President, Chief Accounting Officer and Controller	-
Mr. Andrew P. Hider Director, President, Chief Executive Officer and Interim Group President, Medical Products and Therapies	-
Ms. Jeanne K. Mason Executive Vice President and Chief Human Resources Officer	-
Ms. Patricia B. Morrison Independent Director	0.13m
Dr. Stephen Newman Oesterle, M.D. Independent Director	0.14m
Mr. Jeffrey A. Craig Independent Director	0.04m
Ms. Amy A. Wendell Independent Director	0.12m
Ms. Nancy M. Schlichting Lead Independent Director	0.14m
Mr. Stephen H. Rusckowski Independent Director	0.12m
Mr. James W. Borzi Executive Vice President and Chief Supply Chain Officer	-
Ms. Catherine R. Smith Independent Director	0.15m
Dr. David S. Wilkes, M.D. Independent Director	0.12m
Mr. David S. Rosenbloom Executive Vice President and General Counsel	-
Mr. Reazur Rasul Executive Vice President and Group President, Healthcare Systems and Technologies	-
Mr. William A. Ampofo, II Independent Director	0.11m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	77,827,325
Vanguard Group Inc	62,190,319
Dodge & Cox	57,396,370
Pzena Investment Management, LLC	57,387,040
Dodge & Cox Stock Fund	38,623,700

Director dealings

Date chevron-l-regular chevron-r-regular	Action
31 Dec 2024	-
13 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
09 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Jun 2024	-
03 Jun 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
07 May 2024	-
06 Mar 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.